Hsbc Holdings PLC Has $272.62 Million Holdings in Xylem Inc. $XYL

Posted by Geri Gentry on Jul 3rd, 2026

Hsbc Holdings PLC grew its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 2.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,000,691 shares of the industrial products company’s stock after buying an additional 41,825 shares during the quarter. Hsbc Holdings PLC’s holdings in Xylem were worth $272,622,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also made changes to their positions in the company. World Investment Advisors acquired a new stake in Xylem in the fourth quarter valued at approximately $436,000. Meadowbrook Advisors Group LLC acquired a new position in shares of Xylem during the 4th quarter worth $392,000. Corient Private Wealth LLC raised its holdings in shares of Xylem by 1.1% during the 4th quarter. Corient Private Wealth LLC now owns 44,316 shares of the industrial products company’s stock valued at $6,038,000 after purchasing an additional 499 shares in the last quarter. Bayban acquired a new stake in shares of Xylem in the 4th quarter valued at $71,000. Finally, Reflection Asset Management bought a new stake in Xylem in the fourth quarter worth $1,605,000. Institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

NYSE XYL opened at $118.22 on Friday. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The stock has a market capitalization of $28.10 billion, a PE ratio of 29.41, a P/E/G ratio of 1.67 and a beta of 1.03. The stock has a 50-day simple moving average of $112.72 and a 200 day simple moving average of $124.71.

Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Research analysts anticipate that Xylem Inc. will post 5.51 EPS for the current year.

Xylem Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were given a dividend of $0.43 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s payout ratio is 42.79%.

Insider Buying and Selling at Xylem

In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jerome A. Peribere purchased 1,210 shares of the firm’s stock in a transaction on Monday, May 4th. The stock was bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.32% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on XYL. UBS Group boosted their price target on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Oppenheimer cut their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. Barclays reduced their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a report on Wednesday, April 29th. CLSA raised Xylem to a “hold” rating in a research report on Thursday, June 25th. Finally, Stifel Nicolaus dropped their price target on shares of Xylem from $163.00 to $159.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Eight analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Xylem presently has a consensus rating of “Moderate Buy” and an average price target of $153.54.

Check Out Our Latest Analysis on XYL

Xylem Company Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.